Nucs AI Forms Medical Advisory Board for AI-Driven Theranostics

February 02, 2026
Nucs AI has established a Medical Advisory Board to guide the clinical integration of its AI-based imaging technology in cancer care. The board includes experts from institutions such as UCLA, AstraZeneca, and the European Institute of Oncology.

Nucs AI has formed a Medical Advisory Board to support the adoption of its AI-powered imaging solutions in cancer care, announced in a press release. The board brings together clinical leaders specializing in radiology, nuclear medicine, oncology, and clinical research.

The advisory group will provide guidance on clinical strategy, study design, and responsible implementation of imaging-based AI in nuclear medicine and oncology. Its members include Jeremie Calais of UCLA, A. Omer Nawaz of AstraZeneca, Francesco Ceci of the European Institute of Oncology, and Murray Becker of Rutgers University.

According to the company, the board will help align technology development with real-world clinical practices as Nucs AI advances validation and wider adoption of its platform. The initiative supports the company’s focus on improving precision theranostics through tools such as DeepPSMA, SelectPSMA, and TrackPSMA for prostate cancer management.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

02/02
Oracle Launches AI Data Platform for Life Sciences Research
02/02
XtalPi Introduces AI-Powered XGlue Platform for Molecular Glue Drug Discovery
02/02
Healthcare Triangle Partners with Better.care to Expand Health Data Platforms Across EMEA
01/28
Viveka Health Earns HITRUST e1 Certification with Support from Palindrome Technologies
01/21
EyeContactDX Appoints Dr. Carol Weitzman as Senior Strategic Advisor for AI Autism Screening

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Governing the Future: A Strategic Framework for AI Adoption in Financial Institutions

This whitepaper explores the transformative impact of artificial intelligence on the financial industry, focusing on the governance challenges and regulatory demands faced by banks. It provides a strategic framework for AI adoption, emphasizing the importance of a unified AI approach to streamline compliance and reduce operational costs. The document offers actionable insights and expert recommendations for banks with fewer than 2,000 employees to become leaders in compliant, customer-centric AI.

Read more

You May Also Like